|1.||Nordlander, Margareta: 3 articles (06/2007 - 10/2005)|
|2.||Pestka, James J: 2 articles (05/2013 - 12/2012)|
|3.||Mays, Michelle R: 2 articles (11/2007 - 05/2007)|
|4.||Buckholz, Thomas M: 2 articles (11/2007 - 05/2007)|
|5.||Mahle, Cathy D: 2 articles (11/2007 - 05/2007)|
|6.||DeCarr, Lynn B: 2 articles (11/2007 - 05/2007)|
|7.||Ortiz, Astrid A: 2 articles (11/2007 - 05/2007)|
|8.||Milardo, Lucinda F: 2 articles (11/2007 - 05/2007)|
|9.||Lumb, Kevin J: 2 articles (11/2007 - 05/2007)|
|10.||Björkman, Jan-Arne: 2 articles (09/2006 - 10/2005)|
03/01/2006 - "Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men."
07/01/2009 - "To study the relationship between neuropeptide Y2 receptor (NPY2R) gene rs1047214 polymorphism and obesity or metabolic syndrome in Chinese children and adolescents, in order to provide theoretical evidence for obesity control. "
07/01/2009 - "[Association between obesity and the polymorphism of neuropeptide Y2 receptor gene in children and adolescents]."
11/01/2007 - "No association of sequence variants in the neuropeptide Y2 receptor (NPY2R) gene with early onset obesity in Germans."
05/03/2007 - "Selective activation of the NPY2 receptor to suppress appetite provides an approach to obesity management. "
01/01/2015 - "Blockade of the NPY Y2 receptor suppressed tumor growth in obese mice by affecting tumor angiogenesis. "
01/01/2015 - "Administration of an NPY Y2 receptor antagonist decreased tumor angiogenesis (evaluated as capillary density/mm2) and serum VEGF concentration in the obese group without altering serum VEGF-R1 and NO concentrations. "
01/01/2015 - "The present study examined the effects of the NPY Y2 receptor antagonist on tumor weight, angiogenesis and serum levels of vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGF-R1), and nitric oxide (NO). "
|3.||Body Weight (Weight, Body)
11/01/2007 - "The neuropeptide Y2 receptor (NPY2R) has been implicated in body weight regulation both in humans and rodents. "
05/03/2007 - "Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice."
10/01/2005 - "Neuropeptide Y2 receptors as drug targets for the central regulation of body weight."
09/01/2008 - "Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice."
11/01/2007 - "A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents."
|5.||Mood Disorders (Mood Disorder)
|1.||Messenger RNA (mRNA)
|5.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|7.||Nitric Oxide (Nitrogen Monoxide)
|1.||Vagus Nerve Stimulation